Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 December 2019 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Read more
Prof Koos Albertyn handing over a donation of eleven microscopes to Anzell Spelding, a teacher at Luckhoff Combined School.

With a donation of microscopes, the Department of Microbial, Biochemical and Food Biotechnology at the University of the Free State (UFS) recently contributed to better quality education for a group of 60 learners in the Life Sciences class at the Luckhoff Combined School.

Anzell Spelding, a teacher at the school – with a newly built science laboratory but little equipment – contacted the department a while ago to enquire whether they have any microscopes available to donate. As the department recently acquired a new set of microscopes for undergraduate teaching in the field of Microbiology, ten fully functional microscopes and two other microscopes (for parts) were donated to motivate the learners to choose science as a career.

“This donation puts scientific instruments in the hands of children at an early age, opening their eyes to the possibility of careers in science. Exposing learners to science at an early age can spark enthusiasm and a love of learning that might otherwise never appear,” said Koos Albertyn, Professor in the UFS Department of Microbial, Biochemical and Food Biotechnology.

“These microscopes will enable learners to look at specimens at a microscopic level and therefore access the wonders of natural science at the tiniest and most fascinating level,” he added. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept